Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 2.460
+0.050 (2.07%)
Aug 28, 2026, 4:10 PM AEST
Mesoblast Employees
Mesoblast had 81 employees as of June 30, 2025. The number of employees increased by 8 or 10.96% compared to the previous year.
Employees
81
Change (1Y)
8
Growth (1Y)
10.96%
Revenue / Employee
1.61M AUD
Profits / Employee
-769.59K AUD
Market Cap
3.13B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 81 | 8 | 10.96% |
| Jun 30, 2024 | 73 | -10 | -12.05% |
| Jun 30, 2023 | 83 | 6 | 7.79% |
| Jun 30, 2022 | 77 | -6 | -7.23% |
| Jun 30, 2021 | 83 | -19 | -18.63% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mesoblast News
- 1 day ago - Mesoblast price target raised to $39 from $35 at Piper Sandler - TheFly
- 1 day ago - Mesoblast Reports Substantial Revenue Growth to US$120M - GlobeNewsWire
- 1 day ago - Mesoblast H2 Earnings Call Highlights - MarketBeat
- 1 day ago - Mesoblast Earnings Call Transcript: H2 2026 - Transcripts
- 1 day ago - Mesoblast Annual report: H2 2026 - Filings
- 1 day ago - Mesoblast Slides: H2 2026 - Filings
- 1 day ago - Mesoblast Earnings release: H2 2026 - Filings
- 11 days ago - Mesoblast completes patient treatment in MSB-DR004 in Phase 3 trial - TheFly